Inovio plans human trials for potential Covid-19 vaccine in South Korea in June
Thu, Jun 04, 2020 - 6:48 PM
Experts predict a safe and effective vaccine could take 12 to 18 months to develop.
[SEOUL] Inovio Pharmaceuticals said on Thursday it plans to begin early human trials of its experimental Covid-19 vaccine in South Korea later in June and partnered with non-profit organisation International Vaccine Institute.
The company said the two-stage trial, conducted in...